In the year 2018, molecular technology and large data processing provide great new platforms for understanding to complexity and heterogeneity of prostate tumors and developing strategies to prevent, postpone, or mitigate the migratory and invasive phenotypes of prostate cancer, beyond the AR signaling. This evidence concerns the gene AR and Familial prostate cancer.